Evaluation and treatment of male and female pattern hair loss - 21/08/11
Doi : 10.1016/j.jaad.2004.04.008
Elise A. Olsen, MD a, ⁎, Andrew G. Messenger, MD b, Jerry Shapiro, MD c, Wilma F. Bergfeld, MD d, Maria K. Hordinsky, MD e, Janet L. Roberts, MD f, Dow Stough, MD g, Ken Washenik, MD, PhD h, David A. Whiting, MD i
From the Duke University Medical Center,a Royal Hallamshire Hospital,b University of British Columbia,c Cleveland Clinic,d University of Minnesota,e Oregon Health and Science University,f The Stough Clinic,g Bosley Medical Institute and New York University School of Medicine,h and the Baylor Hair Research and Treatment Centeri USA
Correspondence to: Elise A. Olsen, MD, Professor of Medicine, Duke University Medical Center, Box 3294, Durham, North Carolina 27710.Durham, North Carolina; Sheffield, United Kingdom; Vancouver, Canada; Cleveland, Ohio; Minneapolis, Minnesota; Portland, Oregon; Hot Springs, Arkansas; New York, New York; Beverly Hills, California; and Dallas, Texas
Plan
 | Disclaimer: None of the treatments discussed, particularly those that are not FDA-approved for male pattern hair loss or female pattern hair loss, should be construed as endorsements or specific recommendations for individual patients. These suggestions and opinions are meant to supply an evidence-based record of information from which a physician can make informed judgments about diagnosis and treatment. Funding sources: Although supported in part by an unrestricted educational grant from Galen Corporation/Merck & Co, neither representatives from Galen or Merck & Co were involved in any aspect of the planning, writing, or editing of this manuscript before or after submission for publication. This was an independent project by the authors. Disclosure: All authors have been recipients of research grant funding and have served as consultants and/or principal investigators on at least one research study sponsored by Merck & Co, and Pfizer. None of the authors have any financial interest in any of the companies whose products are discussed here. Reprints not available from authors. |
© 2005
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 52 - N° 2
P. 301-311 - février 2005 Retour au numéro
Article précédent
- Microcystic adnexal carcinoma: Treatment with Mohs micrographic surgery
- Igal Leibovitch, Shyamala C. Huilgol, Dinesh Selva, Karyn Lun, Shawn Richards, Robert Paver
- Mycoplasma pneumoniae–induced Stevens-Johnson syndrome without skin lesions: Fact or fiction?
- Peter C. Schalock, James G.H. Dinulos
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?